Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 23:00:00 10/09/2026 +03			5-day change	1st Jan Change
84.51 ^USD	+0.75%		-5.80%	+27.33%

09-11	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026	CI
09-09	DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

8ef17efae5291d61ec.UdWI004H5MktiDiKkC9G7U4j666Ld_9sr6GysZKYxvA.NZTKnCpTtv4V4Wziw34XmiRUmt_KH4k8nJLr0_2hj50hptGcY0Gqgmb6Xw~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
07-31	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
07-31	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
07-28	UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+12.21%
	ABBOTT LABORATORIES					+14.23%
	MEDTRONIC PLC					+14.01%
	CENCORA, INC.					+14.22%
	HOYA CORPORATION					+31.84%
	BECTON, DICKINSON AND COMPANY					+8.82%
	MEDLINE INC.					+30.98%
	WEST PHARMACEUTICAL SERVICES, INC.					+20.31%
	TERUMO CORPORATION					+38.48%
	SARTORIUS STEDIM BIOTECH					+23.56%
	Average					+20.87%
	Weighted average by Cap.					+17.45%